Keytruda (1 injection, 200 mg)
What's included in this package
Medical Procedures
- Immunotherapy with Keytruda (Pembolizumab)
Duration
Accommodation
4* Hotel
Transport
Transfer airport-clinic-airport
24/7 Bookimed assistance
- Personal medical coordinator
- Medical travel arrangements — booking of air tickets and hotel rooms at special partner prices
- Patient advocacy during medical travel
Program price
What's NOT included in this package
Doctor
Prof. Yeşim (Yesim) Yıldırım — Medical Oncologist at Anadolu Medical Center (since 2011). ESMO-certified specialist, Professor since 2021, author of 80+ scientific publications. Trained at top centers — Rambam (Israel) and Mount Vernon (UK). Treats breast, lung, and gastrointestinal (GI) cancers, as well as melanoma and sarcomas; uses immunotherapy and targeted therapy.
Why patients choose Dr. Yeşim Yıldırım:
- 20+ years of clinical practice; Professor of Medical Oncology since 2021.
- 80+ peer-reviewed publications in tumor biology, immunotherapy, and targeted therapy — treatment plans are based on up-to-date evidence.
- ESMO certification — from Europe’s leading oncology society — confirms high qualification and continuous training to international standards.
How are we doing?
About the clinic
Immunotherapy with Keytruda (Pembrolizumab) is available at Anadolu Medical Center in Gebze, Turkey. One cycle may cost around 160,000 TRY (approximately 3,455 EUR). The clinic follows US standards through its Johns Hopkins Medicine affiliation and holds JCI accreditation.
About the Treatment
Keytruda is an intravenous immunotherapy drug. It helps the immune system fight cancer cells. Each cycle includes the medication and daily inpatient fees for meals and companion stay.
What's Included
- Keytruda medication for one cycle
- Daily inpatient fee covering meals and companion stay
Treatment Process
Patients typically stay 3-5 days for initial diagnostics. Pre-treatment requires PET-CT scans, blood tests, and pathology review. The hospital stay length is determined after evaluation.
Prof. Dr. Eda Şimşek Tanrıkulu leads the oncology team. She specializes in medical oncology and immunotherapy. Her training includes affiliation with Johns Hopkins Hospital.
Clinic Advantages
Anadolu Medical Center is JCI-accredited and ranked among the top 10 hospitals worldwide. It offers a tumor board for treatment planning. Patients can get a free second opinion within 48 hours.
Additional tests like PET-CT or MRI are not included in the base price. Patients pay before each procedure. The treatment protocol adjusts based on individual response.
Contact the clinic to discuss your specific case and treatment plan.
Payment & Rewards
You don’t pay for our services
You make your payment directly at the clinic or to their official bank account.
Some clinics may require a deposit as a part of their policy.
Spread out your payments with installment options.
Earn rewards for referring friends to Bookimed.
Why people love us
Patient reviews
Our top offers for you
FAQ
What is Keytruda (Pembrolizumab)?
Pembrolizumab belongs to the group of the immunotherapy drugs — type of medicine that can treat certain cancers by influencing on patient's immune system. It blocks a protective mechanism of cancer cells and allows the immune system to destroy them. Monoclonal antibody to programmed cell death-1 protein (PD-1) blocks the interaction between PD-1 and its ligands — PD-L1 and PD-L2.
Keytruda prices are specified in this listing. Submit a request to get a personalized quote.
Is Pembrolizumab FDA approved?
On May 23, 2017, the U.S. Food and Drug Administration granted for Pembrolizumab (Keytruda) an accelerated approval — faster approval of drugs for serious conditions that fill an unmet medical need. FDA allowed prescribing immunotherapy new drug to treat patients whose cancers have a specific genetic feature (biomarker).
What are Keytruda success rates?
During the clinical trials of Keytruda, the following indicators were achieved:
|
Period |
The survival rate of patients with 3-4 stages of cancer |
|
6 month |
92% |
|
1 year |
69% |
|
1,5 years |
62% |
|
2 years |
58% |
Who produces Keytruda?
The manufacturer is Merck & Co., Inc. — an American pharmaceutical company and one of the largest pharmaceutical companies in the world. Research performed at Merck has led to FDA approval of 63 new drugs. Company has developed more new drugs than any other company in the USA.